Cite
HARVARD Citation
Wang, Y. et al. (2022). Efficacy and safety of baricitinib in patients with refractory alopecia areata. Dermatologic therapy. 35 (12), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wang, Y. et al. (2022). Efficacy and safety of baricitinib in patients with refractory alopecia areata. Dermatologic therapy. 35 (12), p. n/a. [Online].